Vaxxas
Pre-clinicalVaxxas is commercializing a novel needle-free vaccination technology that enhances the performance of existing and next-generation vaccines.
Founded
2011
Focus
Drug DeliveryVaccines
About
Vaxxas is commercializing a novel needle-free vaccination technology that enhances the performance of existing and next-generation vaccines.
Funding History
3Total raised: $72M
Series C$34MOneVenturesJun 15, 2022
Series B$23MOneVenturesMar 15, 2020
Series A$15MOneVenturesFeb 15, 2018
Company Info
TypePrivate
Founded2011
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile